| Meghan Marie Lees, CRNA | |
|
4608 Waterloo Driv, Ste 170, Columbia, MO 65202 | |
| (314) 306-7902 | |
| Not Available |
| Full Name | Meghan Marie Lees |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 4608 Waterloo Driv, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134543614 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 2014000684 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Moberly Regional Medical Center | Moberly, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson City Medical Group Pc | 1850371089 | 97 |
| Moberly Anesthesia Associates, Llc | 7416083878 | 4 |
News Archive
New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.
Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.
Many people who suffer a stroke are permanently disabled. Stroke remains the leading cause of long-term disability in the United States.
On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.
› Verified 6 days ago
| Entity Name | Metro-west Anesthesia Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245427335 PECOS PAC ID: 2163329921 Enrollment ID: O20031218000563 |
News Archive
New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.
Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.
Many people who suffer a stroke are permanently disabled. Stroke remains the leading cause of long-term disability in the United States.
On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.
› Verified 6 days ago
| Entity Name | Jefferson City Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336189398 PECOS PAC ID: 1850371089 Enrollment ID: O20040908000924 |
News Archive
New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.
Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.
Many people who suffer a stroke are permanently disabled. Stroke remains the leading cause of long-term disability in the United States.
On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.
› Verified 6 days ago
| Entity Name | Moberly Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598737850 PECOS PAC ID: 7416083878 Enrollment ID: O20100325000204 |
News Archive
New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.
Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.
Many people who suffer a stroke are permanently disabled. Stroke remains the leading cause of long-term disability in the United States.
On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.
› Verified 6 days ago
| Entity Name | Fulton Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1417367665 PECOS PAC ID: 7810211398 Enrollment ID: O20150123001617 |
News Archive
New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.
Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.
Many people who suffer a stroke are permanently disabled. Stroke remains the leading cause of long-term disability in the United States.
On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.
› Verified 6 days ago
| Entity Name | Capital Anesthesia Solutions Of Missouri, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770185472 PECOS PAC ID: 1456764885 Enrollment ID: O20210104001560 |
News Archive
New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.
Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.
Many people who suffer a stroke are permanently disabled. Stroke remains the leading cause of long-term disability in the United States.
On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.
› Verified 6 days ago
| Entity Name | Noble Health Audrain Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447841168 PECOS PAC ID: 0446667299 Enrollment ID: O20210430001237 |
News Archive
New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.
Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.
Many people who suffer a stroke are permanently disabled. Stroke remains the leading cause of long-term disability in the United States.
On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meghan Marie Lees, CRNA 209 S Main St, Ste 170, Poplar Bluff, MO 63901-5831 Ph: (573) 686-5550 | Meghan Marie Lees, CRNA 4608 Waterloo Driv, Ste 170, Columbia, MO 65202 Ph: (314) 306-7902 |
News Archive
New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.
Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.
Many people who suffer a stroke are permanently disabled. Stroke remains the leading cause of long-term disability in the United States.
On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.
› Verified 6 days ago
Mrs. Megan Elaine Hilderbrand, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
Kimberly Ann Frazier, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
Melissa Grcic-jacobelli, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 573-882-2226 | |
Allyson J Ihms, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 210 Portland St Ste 100, Columbia, MO 65201 Phone: 573-777-8818 Fax: 573-777-8819 | |
Zebulon E Thomeczek, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 573-882-2226 | |
Matthew Ryan Nanney, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-2568 Fax: 855-903-0985 | |
William L Johnson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1106 Yiotis Way, Columbia, MO 65203 Phone: 573-673-6861 Fax: 573-443-2905 |